蒽环类药物
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-bis(2,4-dicarboxyl)benzoate | 1190845-33-0 | C49H39NO21 |
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-bis(3-fluoro-2-carboxyl)benzoate | 1190845-27-2 | C47H37F2NO17 |
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-hydrogen disuccinate | 1190845-20-5 | C39H39NO17 |
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-bis(6-fluoro-2-carboxyl)benzoate | 1190845-29-4 | C47H37F2NO17 |
| —— | 7-O-<3-(3(R/S)-cyanomorpholin-4-yl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl>-ε-rhodomycinone | 132817-55-1 | C33H36N2O12 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-(2,2-dimethyl)glycinate hydrochloride | 1190845-42-1 | C35H38N2O12*ClH |
| —— | 3'-(pyrido-(2,3)succinimido)doxorubicin-14-oxo-hydrogen succinate | 1190845-18-1 | C38H34N2O16 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-(3,4,5,6-tetrafluoro-2-carboxyl)benzoate | 1190845-30-7 | C39H31F4NO14 |
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-hydrogen diglutarate | 1190845-24-9 | C41H43NO17 |
| —— | 7-O-<2,3,6-Trideoxy-3-(morpholin-4-yl)-α-L-lyxo-hexopyranosyl>-ε-isorhodomycinone | 127903-63-3 | C32H37NO13 |
| —— | 7-O-<2,3,6-Trideoxy-3-(morpholin-4-yl)-α-L-lyxo-hexopyranosyl>-ε-rhodomycinone | 132817-54-0 | C32H37NO12 |
| —— | 3'-(benzo-(2,3)succinimido)doxorubicin-14-oxo-glycinate hydrochloride | 1190845-53-4 | C37H34N2O14*ClH |
| —— | 1497404-32-6 | C51H62N6O17 | |
| —— | 7-O-<3-(3-(R/S)-cyanomorpholin-4-yl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl>-ε-isorhodomycinone | 127903-64-4 | C33H36N2O13 |
| —— | 7-O-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)adriamycinone | 105444-07-3 | C32H32O16 |
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-bis(3,4,5,6-tetrafluoro-2-carboxyl)benzoate | 1190845-31-8 | C47H31F8NO17 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-glycinate hydrochloride | 1190845-40-9 | C33H34N2O12*ClH |
| —— | 3'-glutarimidodoxorubicin | 1190845-06-7 | C32H33NO13 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-hydrogen glutarate | 1190845-23-8 | C36H37NO14 |
| —— | 3'-pyrrolyldoxorubicin-14,4'-oxo-bis(2-carboxyl)benzoate | 1190845-34-1 | C47H39NO17 |
| —— | 3'-pyrrolyldoxorubicin-14-oxo-(3-fluoro-2-carboxyl)benzoate | 1190845-26-1 | C39H34FNO14 |
| —— | 3'-maleimidodoxorubicin | 1190845-07-8 | C31H29NO13 |
| —— | 3'-(pyrido-(2,3)succinimido)doxorubicin | 1190845-09-0 | C34H30N2O13 |
| —— | 7-O-<4-O-<4-O-(2,3,6-trideoxy-α-L-glycero-hexopyranosid-4-ulosyl)-2,6-dideoxy-α-L-lyxo-hexopyranosyl>-2,6-dideoxy-2-iodo-α-L-talopyranosyl>daunomycinone | 129985-44-0 | C39H45IO16 |
| —— | 3'-glutarimidodoxorubicin-14-oxo-hydrogen succinate | 1190845-16-9 | C36H37NO16 |
| —— | 7-O-<4-O-<4-O-(2,3,6-trideoxy-α-L-glycero-hexopyranosid-4-ulosyl)-2,6-dideoxy-α-L-lyxo-hexopyranosyl>-2,6-dideoxy-2-iodo-α-L-talopyranosyl>daunomycinone | 129985-44-0 | C39H45IO16 |
| —— | 7-O-(3,5-di-O-acetyl-β-D-ribofuranosyl)daunomycinone | 105444-02-8 | C30H30O14 |
| —— | 3'-succinimidodoxorubicin-14-oxo-hydrogen succinate | 1190845-15-8 | C35H35NO16 |
| —— | 3'-(benzo-(2,3)succinimido)doxorubicin | 1190845-10-3 | C35H31NO13 |
| —— | 4'-epi-N-trifluoroacetyl-4'-trifluoromethanesulfonyldaunorubicin | 83000-48-0 | C30H27F6NO13S |
| —— | 4'-deoxy-N-trifluoroacetyldaunorubicin | 83000-50-4 | C29H28F3NO10 |
| —— | 3'-(benzo-(2,3)succinimido)doxorubicin-14-oxo-hydrogen succinate | 1190845-19-2 | C39H35NO16 |
| —— | 7-O-(5-O-acetyl-β-D-ribofuranosyl)daunomycinone | 105444-03-9 | C28H28O13 |
| —— | 4-Nitro-benzoic acid (2R,3R,4S,6S)-6-((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-2-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-3-yl ester | 76793-59-4 | C36H31F3N2O14 |
| —— | 3'-maleimidodoxorubicin-14-oxo-hydrogen succinate | 1190845-17-0 | C35H33NO16 |
| —— | 3'-maleimidodoxorubicin-14-oxo-glycinate hydrochloride | 1190845-51-2 | C33H32N2O14*ClH |
| —— | 7-O-<4-O-<4-O-(2,3,6-trideoxy-α-L-glycero-hexopyranosid-4-ulosyl)-2,6-dideoxy-3-O-(trimethylsilyl)-α-L-lyxo-hexopyranosyl>-2,6-dideoxy-2-iodo-3-O-(trimethylsilyl)-α-L-talopyranosyl>daunomycinone | 129985-43-9 | C45H61IO16Si2 |
| —— | (7S,9S)-(+)-idarubicinone-7-α-D-galactose | 1232835-34-5 | C26H26O12 |
| —— | 742091-75-4 | C52H55N9O19S2 | |
| —— | 14-Bromo 4'-epi-Daunorubicin Hydrochloride | 99530-17-3 | C27H28BrNO10*ClH |
| —— | DOX-mPEG7-GA3 | 1184951-71-0 | C60H77N5O28 |
| —— | (1-methyl-5-nitroimidazol-2-yl)methyl (5aS,6S,8R,9aS)-6-methyl-8-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-2,5a,6,8,9,9a-hexahydropyrano[4,3-f][1,3,5]dioxazepine-1-carboxylate | 864923-95-5 | C35H36N4O16 |
| —— | 7-O-<4-O-<4-O-(2,3,6-trideoxy-α-L-glycero-hexopyranosid-4-ulosyl)-2,6-dideoxy-α-L-lyxo-hexopyranosyl>-2,6-dideoxy-α-L-galactopyranosyl>daunomycinone | 129985-45-1 | C39H46O16 |
| —— | Zoptarelin Doxorubicin Acetate | 1928750-34-8 | C97H129N19O32 |
| —— | 7-O-(2,3,5-tri-O-acetyl-D-ribofuranosyl)daunomycinone | 105444-01-7 | C32H32O15 |
| —— | Acetic acid (2S,3S,4S,6S)-3-acetoxy-2-methyl-6-((1R,2S,3S)-3,10,12-trihydroxy-2-methoxy-3-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-tetrahydro-pyran-4-yl ester | 146061-72-5 | C30H30O13 |
| —— | [4-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phenyl]methyl (5aS,6S,8R,9aS)-8-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-6-methyl-2,5a,6,8,9,9a-hexahydropyrano[4,3-f][1,3,5]dioxazepine-1-carboxylate | 864923-98-8 | C42H42N4O16 |
| —— | (7S)-O-(2'-O-(3''-acetamido-2'',3'',6''-trideoxy-α-L-lyxopyranosyloxy)ethyl)daunomycinone | 120313-62-4 | C31H35NO12 |
| —— | (7S,9S)-14-O-(tert-butyldimethylsilyl)-4-demethoxy-7-O-(2,6-dideoyxy-2-iodo-α-L-mannopyranosyl)adriamycinone | 92689-48-0 | C32H39IO11Si |
| —— | (7R,9R)-4-demethoxy-7-O-(2,6-dideoxy-2-iodo-α-L-mannopyranosyl)adriamycinone | 92761-46-1 | C26H25IO11 |
联系我们
关注我们
公众号
